If you’ve been using a GLP-1 such as semaglutide, then you’ve likely experienced the powerful effects of this weight loss ...

An obesity medicine physician writes that weight-loss drugs such as Ozempic have been getting a bad rap, almost as if those ...

The popular weight-loss drugs known as GLP-1 receptor agonists, which were originally meant to treat diabetes, surged in ...

In the first half of 2025, Ozempic developer Novo Nordisk in Bagsværd, Denmark, expects results from a second phase III trial ...

Studies have suggested that GLP-1RAs may show promise for a host of conditions, from alcohol use disorder to Parkinson’s. But ...

The search for effective weight loss solutions has led to countless diet trends, fitness regimens, and medical interventions.

A new study increases max-dose guidance for semaglutide. This offers hope for those who didn’t reach their weight goals. The ...

In a world where weight loss struggles are increasingly ... by years of clinical research. Semaglutide and tirzepatide have demonstrated consistent success in helping individuals lose weight.

Dr. Sue Mitchell is an experienced gastroenterologist with a background in functional medicine, internal medicine and ...

Following her drastic weight loss she struggled with sagging skin and the dreaded droopy “Ozempic butt,” leaving her newly-taut body looking drab. So, to celebrate her svelte success ...

What's the most attractive weight-loss stock right now? We asked Seeking Alpha analysts Edmund Ingham, Stephen Ayers and Oneil Trader for their picks. Read more here.